Photo courtesy of Aegis Life.
Aegis Life is developing Covigenix, a pan-coronavirus DNA vaccine based on its Fusogenix drug delivery technology.

Photo courtesy of Aegis Life. Aegis Life is developing Covigenix, a pan-coronavirus DNA vaccine based on its Fusogenix drug delivery technology.

San Diego-based Aegis Life, a biotechnology company developing vaccines and therapies for life-threatening diseases, has entered the race to combat COVID-19 with its DNA vaccine...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99